Skip to main content
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.684
-0.026 (-3.66%)
At close: Dec 20, 2024, 4:00 PM
0.680
-0.004 (-0.58%)
After-hours: Dec 20, 2024, 7:45 PM EST

Unicycive Therapeutics Revenue

In the year 2023, Unicycive Therapeutics had annual revenue of $675.00K, down -29.02%.

Revenue (ttm)
$675.00K
Revenue Growth
-29.02%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
71.00M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023675.00K-276.00K-29.02%
Dec 31, 2022951.00K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owlet 78.58M
Generation Bio Co. 18.58M
Armata Pharmaceuticals 5.47M
Ovid Therapeutics 631.70K
Genelux 8.00K
Revenue Rankings

UNCY News

More News